PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING TAXANE DERIVATIVES
摘要
The present invention relates to a novel intravenous formulation for a taxane chemotherapeutic agent. The agent is formulated with ethanol, polyoxyethylated castor oil and a mixture of antioxidants to prevent oxidation of the drug substance caused by the polyoxyethylated castor oil.